Affiliation:
1. Department of Dermatology, Singapore General Hospital , Singapore
Abstract
Scrotal erythema is a rare adverse effect of cabozantinib, a tyrosine kinase inhibitor. In patients receiving cabozantinib who develop scrotal erythema, the drug is a specific clue that should be considered by dermatologists when faced with this unique rash, which may be underrecognized.
Publisher
Oxford University Press (OUP)